CarePath Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$335K
- Investors
-
6
CarePath General Information
Description
Developer of a patient monitoring technology designed for urologic care at home. The company's technology increases patient compliance and data accuracy, confident and appropriate diagnoses, patient satisfaction and comfort, and decreases overall healthcare costs, enabling patients to get access to a system that provides real-time insights into patient symptoms to find optimal treatment and personalized treatment plans, improves patient satisfaction and comfort, and reduces overall healthcare costs.
Contact Information
Website
www.carepathurology.comCorporate Office
- 1600 Accelerator Way
- Suite 360
- Knoxville, TN 37920
- United States
Corporate Office
- 1600 Accelerator Way
- Suite 360
- Knoxville, TN 37920
- United States
CarePath Timeline
CarePath Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 07-Nov-2025 | $335K | Completed | Generating Revenue | ||
| 3. Early Stage VC | Completed | Generating Revenue | ||||
| 2. Early Stage VC (Series A) | 29-Mar-2024 | $16M | $16M | Completed | Generating Revenue | |
| 1. Grant | 21-Mar-2023 | $50K | Completed | Generating Revenue |
CarePath Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-6 | ||||||||
| Series A-5 | ||||||||
| Series A-4 | ||||||||
| Series A-3 | ||||||||
| Series A-2 | 2,109,703 | $0.000010 | $0.02 | $0.5 | $0.5 | 1x | $0.5 | 5.6% |
| Series A-1 | 19,386,566 | $0.000010 | $0.03 | $0.69 | $0.69 | 1x | $0.69 | 38.81% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
CarePath Comparisons
Industry
Financing
Details
CarePath Competitors (2)
One of CarePath’s 2 competitors is Accuryn, a Venture Capital-Backed company based in Hayward, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Accuryn | Venture Capital-Backed | Hayward, CA | ||||
| ClearTrac Technologies | Corporation | Knoxville, TN |
CarePath Signals
CarePath Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Jumpstart Capital (Tennessee) | Venture Capital | Minority | ||
| Laborie Medical Technologies | PE-Backed Company | Minority | ||
| Launch Tennessee | Not-For-Profit Venture Capital | Minority | ||
| Solas BioVentures | Venture Capital | Minority | ||
| PYA (Knoxville) | Corporation |
CarePath FAQs
-
When was CarePath founded?
CarePath was founded in 2020.
-
Where is CarePath headquartered?
CarePath is headquartered in Knoxville, TN.
-
What is the size of CarePath?
CarePath has 15 total employees.
-
What industry is CarePath in?
CarePath’s primary industry is Monitoring Equipment.
-
Is CarePath a private or public company?
CarePath is a Private company.
-
What is CarePath’s current revenue?
The current revenue for CarePath is .
-
How much funding has CarePath raised over time?
CarePath has raised $19.4M.
-
Who are CarePath’s investors?
Jumpstart Capital (Tennessee), Laborie Medical Technologies, Launch Tennessee, Solas BioVentures, and PYA (Knoxville) are 5 of 6 investors who have invested in CarePath.
-
Who are CarePath’s competitors?
Accuryn and ClearTrac Technologies are competitors of CarePath.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process